HOUSTON — Houston Texans receiver Tank Dell will miss the remainder of the season after dislocating a knee and tearing an ACL in a loss to Kansas City on Saturday. Coach DeMeco Ryans revealed the details of his injury Monday before announcing that Dell would have season-ending surgery for a second straight year. He fractured his fibula in Week 13 against the Broncos as a rookie last season and had surgery on it the following day. “He dislocated the knee, he tore the ACL, other things there he’ll have to get repaired," Ryans said. “So he’ll be out for the year.” Ryans didn't have a date for Dell's surgery for this injury, but said it would be soon. The Texans placed Dell on injured reserve and claimed receiver Diontae Johnson off waivers from Baltimore. Johnson joins his third team this year after his brief and rocky tenure with the Ravens, who acquired him in a trade with Carolina. Johnson was suspended by the Ravens and later waived after the team said he refused to enter a game against Philadelphia. Houston hosts Baltimore on Christmas Day. Dell was injured on a 30-yard touchdown catch in Houston’s 27-19 loss Saturday. He was coming across the back of the end zone and made the spectacular catch on a pass from C.J. Stroud before colliding with Houston teammate Jared Wayne on the way to the ground. Dell immediately grabbed at his knee and Wayne signaled for team trainers, who spent several minutes working on the wide receiver while teammates waited anxiously. Dell was eventually placed on a stretcher and driven in a covered medical cart off the field, and then he was taken to the hospital. He stayed in the hospital overnight before flying back to Houston on Sunday. Stroud, who is so close to Dell that he considers him a brother, cried the entire time the receiver was down on the field and for a while after he was taken away. “It was just not easy for me to sit there and be emotional,” Stroud said Monday. “But it’s something that we all go through in life and it’s easy to be a fake tough guy. It’s easy to go through life acting like everything doesn’t affect you, but deep down we all know we’re going through something.” Some criticized Stroud for crying. But he believes a display of emotion such as that was important to remind people of the human aspect of this game and the toll it can take on players. “It’s good for young men and women out there, kids who are brought up — and I was taught this too as a kid, not from my parents but just from the world, don’t let anybody see you emotional,” he said. “Don’t let anybody see you down and yeah there’s some truth to that in in certain aspects, but there’s also life and I think it was good for people to see me in that light and knowing that there is still a human factor to me and I’m a normal person.” CLEVELAND — Two days before recording another milestone, resume-building sack on Sunday at Cincinnati, Myles Garrett delivered a jarring hit — on the Browns. In this case, any roughness could be deemed necessary. Garrett piled on to what has been a painful and puzzling season in Cleveland by saying he doesn't have any interest in going through another rebuild and wants to know exactly what the organization's offseason plans are to fix things. If that wasn't enough, Garrett indicated for the first time that he would consider leaving the Browns if his vision doesn't mesh with the team's ambitions. “It’s a possibility,” he said of playing elsewhere. "But I want to be a Cleveland Brown. I want to play my career here.” It's unclear how Garrett's comments were received by owners Dee and Jimmy Haslam, who have plenty to consider as the Browns (3-12) head into the final two weeks of a season that began with playoff expectations and could be followed by upheaval. The Browns haven't been this bad since going 0-16 in 2017. Aaron Rodgers is still contemplating his playing future. The star quarterback knows if he returns to the field, it might be out of hands whether it's with the New York Jets. The 41-year-old Rodgers said last week that he'll take some time after this season, his 20th in the NFL, to determine what he wants to do next. On Monday, he suggested a decision on whether he'll return with the Jets could be made for him the day after the team's regular-season finale. “I think there’s a world where they just say, ‘Hey, thank you, we’re going to go in another direction’ on Jan. 6,” Rodgers said during his weekly appearance on “The Pat McAfee Show.” “That’s a possibility,” he added. "I think there’s also a possibility we’re going to wait and see who the new staff is.” Get local news delivered to your inbox!Association of Ghana Startups calls on John Mahama to prioritize the passage of Startup Bill
Barclays PLC increased its position in shares of ImmunityBio, Inc. ( NASDAQ:IBRX – Free Report ) by 127.4% during the 3rd quarter, Holdings Channel reports. The firm owned 361,036 shares of the company’s stock after acquiring an additional 202,248 shares during the period. Barclays PLC’s holdings in ImmunityBio were worth $1,344,000 at the end of the most recent reporting period. Other large investors also recently modified their holdings of the company. Captrust Financial Advisors purchased a new position in ImmunityBio in the 3rd quarter worth approximately $41,000. Algert Global LLC purchased a new stake in ImmunityBio during the 2nd quarter valued at approximately $86,000. Dimensional Fund Advisors LP bought a new stake in shares of ImmunityBio during the second quarter valued at approximately $105,000. CIBC Asset Management Inc purchased a new position in shares of ImmunityBio in the second quarter worth $118,000. Finally, Mercer Global Advisors Inc. ADV purchased a new stake in ImmunityBio in the 2nd quarter worth $126,000. Hedge funds and other institutional investors own 8.58% of the company’s stock. ImmunityBio Stock Performance Shares of NASDAQ IBRX opened at $2.78 on Friday. ImmunityBio, Inc. has a 52-week low of $2.50 and a 52-week high of $10.53. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of -3.02 and a beta of 0.86. The stock has a 50 day moving average price of $4.40 and a 200 day moving average price of $4.61. Analysts Set New Price Targets Read Our Latest Analysis on IBRX ImmunityBio Profile ( Free Report ) ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA, and recombinant protein vaccines; and cell therapies. Recommended Stories Want to see what other hedge funds are holding IBRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ImmunityBio, Inc. ( NASDAQ:IBRX – Free Report ). Receive News & Ratings for ImmunityBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunityBio and related companies with MarketBeat.com's FREE daily email newsletter .
Nazarbayev University Crisis: Shigeo Katsu Demands Audit Transparency
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Rapid TP/HIV Test (Multiplo® TP/HIV) to be rolled out across Canada, a critical point-of-care tool to address the health crises with HIV and syphilis in Canada. The single Reveal® TP (Syphilis) approval will follow soon after this more complex approval. The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately. This easy-to-use and high-quality test can be used in any setting and does not need any special storage conditions. Making it the perfect solution for use in hospitals, doctor's offices and other settings and provides another important option in the Canadian market to help people know their status and get connected to treatment and care. "Our Multiplo® TP/HIV device is the fastest testing solutions for HIV-1/2 and Syphilis and has been used in various settings and markets (such as in Europe, Colombia etc) for years. The Health Canada Medical Device License for professional-use will immediately address critical gaps in healthcare settings at a fraction of the costs of conventional testing systems," said Hermes Chan, CEO of MedMira, a world leader in developing rapid diagnostics and technologies. "Together with REACH Nexus we aim to supply urban and remote communities across Canada, and with it provide access to a critical needed screening tool. This test will have a significant impact on the already stretched and overburdened health care system by providing a fast and cost-efficient screening method." Health Canada's licensure of the device is based on the results of a landmark clinical study in Alberta, co-led by Dr. Sean B. Rourke, director of REACH Nexus and a scientist with the MAP Centre for Urban Health Solutions at St. Michael's Hospital (Unity Health Toronto) and Dr. Ameeta Singh at the University of Alberta. "We urgently need more rapid testing options approved in Canada to reach the undiagnosed with HIV, syphilis and other blood-borne infections and sexually transmitted infections (STBBIs)," said Dr. Rourke, the director of REACH Nexus at MAP. "We are very excited about this ongoing partnership with MedMira and the critical implementation science work that went into getting this device approved and into the hands of healthcare professionals." Health Canada's approval of the Multiplo® TP/HIV rapid test couldn't come at a more urgent time. The latest data from the Public Health Agency of Canada, shows that new HIV diagnoses soared more than 35% from 2022 to 2023, with rates in Manitoba rising by more than 40%. In Saskatchewan, the rate of HIV was 19.4 per 100,000 people, more than three times the national rate. In 2022, there were 13,953 reported syphilis cases, with rates increasing by 109% compared to 2018, and with congenital syphilis cases seeing a 7% increase from 2021 and a 599% increase from 2018(1). With the rising cases, particularly in underserved and remote communities, the Multiplo® TP/HIV provides an essential testing device to help reach the undiagnosed living with HIV and/or syphilis. "These tests are essential amid the rising number of STBBIs and will have real-life impacts," said Dr. Rourke. "Not everyone has access to the testing they need for STBBIs because of health inequities, stigma and various forms of discrimination. MedMira's rapid test is a crucial tool in Canada - so everyone can have access to the testing they need." As part of Health Canada's review and authorization process, Dr. Rourke's team of researchers sourced funding and conducted the landmark studyworking closely with healthcare providers, provincial health ministry and laboratory agencies, community stakeholders, and people with lived experience. The study, conducted from 2020-2022, included over 1,500 participants from clinical settings in Edmonton and northern Alberta. The study found the Multiplo® TP/HIV test to be 100 per cent accurate in identifying HIV infection, and more than 98 per cent accurate in detecting syphilis. "Having more HIV rapid tests increases our chances of reaching people in Canada who have HIV and don't know it, and a very significant and increasing number of infectious and congenital syphilis cases" said Dr. Rourke. "This rapid, accessible test helps breakdown barriers that some people face so they can get tested so they know their status. It helps move closer to ending the HIV and syphilis epidemics in Canada." (1) https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-canada-surveillance-report-december-31-2022.html About REACH Nexus at MAP Centre for Urban Health Solutions REACH Nexus is an ambitious national research group working on how to address HIV, Hepatitis C, and other sexually transmitted and blood-borne infections (STBBIs) in Canada. Their focus is on reaching the undiagnosed, implementing and scaling up new testing options, strengthening connections to care, improving access to options for prevention (PrEP and PEP) and ending stigma. We work in collaboration and partnership with people living with HIV; community-based organizations; front-line service providers; healthcare providers and decision makers; public health agencies; researchers; business leaders; industry partners, and federal, provincial and regional policymakers.REACH Nexus is part of MAP Centre for Urban Health Solutions at St. Michael's Hospital, Unity Health Toronto, and is funded by the Canadian Institutes of Health Research. Follow us on Twitter, Instagram and Facebook. About MedMira MedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The Company's tests provide hospitals, labs, clinics, and individuals with instant disease diagnosis, such as HIV, Syphilis, Hepatitis, and SARS-CoV-2, in just three easy steps. The Company's tests are sold globally under the REVEAL®, REVEALCOVID-19®, Multiplo® and Miriad® brands. Based on its patented Rapid Vertical Flow® Technology, MedMira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit medmira.com . Follow us on Twitter and LinkedIn . This news release contains forward‐looking statements, which involve risk and uncertainties and reflect the Company's current expectation regarding future events, including statements regarding possible regulatory approval, product launch, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. MedMira Contact Markus Meile Chief Financial Officer MedMira Inc. ir@medmira.com REACH Nexus Contact Andrew Russell Senior Communications Specialist REACH Nexus - MAP Centre for Urban Health Solutions andrew.russell@unityhealth.to SOURCE: MedMira Inc. View the original on accesswire.com
Michael Owen names ‘the sad thing about Man Utd these days’ as ex-Old Trafford hero slams ‘stupid’ new signing
HOUSTON — Houston Texans receiver Tank Dell will miss the remainder of the season after dislocating a knee and tearing an ACL in a loss to Kansas City on Saturday. Coach DeMeco Ryans revealed the details of his injury Monday before announcing that Dell would have season-ending surgery for a second straight year. He fractured his fibula in Week 13 against the Broncos as a rookie last season and had surgery on it the following day. “He dislocated the knee, he tore the ACL, other things there he’ll have to get repaired," Ryans said. “So he’ll be out for the year.” Ryans didn't have a date for Dell's surgery for this injury, but said it would be soon. Dell was injured on a 30-yard touchdown catch in Houston’s 27-19 loss Saturday. He was coming across the back of the end zone and made the spectacular catch on a pass from C.J. Stroud before colliding with Houston teammate Jared Wayne on the way to the ground. Dell immediately grabbed at his knee and Wayne signaled for team trainers, who spent several minutes working on the wide receiver while teammates waited anxiously. Dell was eventually placed on a stretcher and driven in a covered medical cart off the field, and then he was taken to the hospital. He stayed in the hospital overnight before flying back to Houston on Sunday. Stroud, who is so close to Dell that he considers him a brother, cried the entire time the receiver was down on the field and for a while after he was taken away. “It was just not easy for me to sit there and be emotional,” Stroud said Monday. “But it’s something that we all go through in life and it’s easy to be a fake tough guy. It’s easy to go through life acting like everything doesn’t affect you, but deep down we all know we’re going through something.” Some criticized Stroud for crying. But he believes a display of emotion such as that was important to remind people of the human aspect of this game and the toll it can take on players. “It’s good for young men and women out there, kids who are brought up — and I was taught this too as a kid, not from my parents but just from the world, don’t let anybody see you emotional,” he said. “Don’t let anybody see you down and yeah there’s some truth to that in in certain aspects, but there’s also life and I think it was good for people to see me in that light and knowing that there is still a human factor to me and I’m a normal person.” CLEVELAND — Two days before recording another milestone, resume-building sack on Sunday at Cincinnati, Myles Garrett delivered a jarring hit — on the Browns. In this case, any roughness could be deemed necessary. Garrett piled on to what has been a painful and puzzling season in Cleveland by saying he doesn't have any interest in going through another rebuild and wants to know exactly what the organization's offseason plans are to fix things. If that wasn't enough, Garrett indicated for the first time that he would consider leaving the Browns if his vision doesn't mesh with the team's ambitions. “It’s a possibility,” he said of playing elsewhere. "But I want to be a Cleveland Brown. I want to play my career here.” It's unclear how Garrett's comments were received by owners Dee and Jimmy Haslam, who have plenty to consider as the Browns (3-12) head into the final two weeks of a season that began with playoff expectations and could be followed by upheaval. The Browns haven't been this bad since going 0-16 in 2017. Aaron Rodgers is still contemplating his playing future. The star quarterback knows if he returns to the field, it might be out of hands whether it's with the New York Jets. The 41-year-old Rodgers said last week that he'll take some time after this season, his 20th in the NFL, to determine what he wants to do next. On Monday, he suggested a decision on whether he'll return with the Jets could be made for him the day after the team's regular-season finale. “I think there’s a world where they just say, ‘Hey, thank you, we’re going to go in another direction’ on Jan. 6,” Rodgers said during his weekly appearance on “The Pat McAfee Show.” “That’s a possibility,” he added. "I think there’s also a possibility we’re going to wait and see who the new staff is.” Get local news delivered to your inbox!
STUART, Fla. , Dec. 24, 2024 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, today announced the closing of its initial public offering of 2,300,000 shares of its Class A common stock at a public offering price of $4.00 per share, for gross proceeds of $9,200,000 , before deducting underwriting discounts, commissions, and estimated offering expenses. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Top trending stories from the past week. News, Sports, and more throughout the week. The week's obituaries, delivered to your inbox.Rocket scientist’s cast-iron pan threatens to topple Le Creuset( MENAFN - EQS Group) , 12/23/2024 / 16:15, EST/EDT - EQS Newswire - Ares Dynamic Credit Allocation Fund (NYSE) Ares Capital Management II LLC today announced that monthly fund composition and performance data for Ares Dynamic Credit Allocation Fund, Inc. (NYSE:ARDC) as of November 30, 2024 is now available via About Ares Dynamic Credit Allocation Fund, Inc. Ares Dynamic Credit Allocation Fund, Inc. ("ARDC") is a closed-end management company that is externally managed by Ares Capital Management II LLC, a subsidiary of Ares Management Corporation. ARDC seeks to provide an attractive level of total return, primarily through current income and, secondarily, through capital appreciation. ARDC invests in a broad, dynamically-managed portfolio of credit investments. There can be no assurance that ARDC will achieve its investment objective. ARDC's net asset value may be accessed through its NASDAQ ticker symbol, XADCX. Additional information is available at This document is not an offer to sell securities and is not soliciting an offer to buy securities in any jurisdiction where the offer or sale is not permitted. An investor should consider the investment objective, risks, charges and expenses of ARDC carefully before investing. ARDC is a closed-end fund, which does not engage in continuous offerings of its shares. Since its initial public offering, ARDC has traded on the New York Stock Exchange under the symbol ARDC . Investors wishing to purchase or sell shares may do so by placing orders through a broker dealer or other intermediary. Contact Ares Dynamic Credit Allocation Fund, Inc. John Stilmar ... (888) 818-5298 or Destra Capital Advisors LLC ... (877) 855-3434 SOURCE: Ares Dynamic Credit Allocation Fund 12/23/2024 EQS Newswire / EQS Group MENAFN23122024004691010666ID1109025689 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.Share Tweet Share Share Email Managing personal finances has become a crucial skill. With the rise of consumer culture and the ease of online shopping, many individuals find themselves caught in cycles of impulsive spending and financial stress. Mindful spending and saving—an intentional approach to managing money—has emerged as a powerful solution to this problem. Thankfully, technology now offers a range of apps designed to help individuals cultivate better financial habits. Understanding Mindful Spending Mindful spending involves making deliberate decisions about where and how to use your money. It requires a conscious effort to align your expenditures with your values, goals, and priorities. Unlike impulsive purchases, mindful spending promotes a sense of control and satisfaction, reducing buyer’s remorse and fostering long-term financial stability. To practice mindful spending, it’s important to: Set Clear Financial Goals: Whether you’re saving for a house, a vacation, or retirement, having specific goals helps prioritize spending. Track Your Expenses: Awareness of where your money goes can reveal patterns and areas for improvement. Evaluate Needs vs. Wants: Distinguishing between essentials and luxuries is key to staying on track. Reflect on Purchases: Taking a moment to consider the necessity and value of an item can prevent impulse buys. How Saving Apps Promote Financial Intentionality Saving apps serve as digital tools to streamline the process of setting aside money for future needs. They help automate savings, provide insights into spending habits, and create a structured approach to financial planning. Here’s how they foster mindful financial behavior: Automation: Apps like Acorns and Digit use algorithms to automatically transfer small amounts of money into savings accounts based on your spending patterns. This reduces the mental effort required to save consistently. Customization: Many apps allow users to set personalized saving goals and monitor their progress. Visualization: Interactive charts and summaries provide a clear picture of financial health, encouraging intentional decision-making. Top Mindful Spending and Saving Apps Let’s delve into some popular apps that promote mindful financial choices: YNAB (You Need A Budget) YNAB emphasizes the principle of giving every dollar a job. This budgeting app helps users allocate their income to specific categories such as rent, groceries, and entertainment. By encouraging proactive planning, YNAB fosters mindfulness in spending. Mint Mint offers a comprehensive platform for tracking expenses, setting budgets, and monitoring credit scores. Its user-friendly interface consolidates all financial accounts, providing a holistic view of your financial space. PocketGuard This app simplifies budgeting by showing how much disposable income you have after accounting for bills, goals, and necessities. It’s a practical tool for those prone to overspending. Acorns Acorns focuses on micro-investing and saving by rounding up your purchases to the nearest dollar and investing the spare change. This app is ideal for individuals looking to grow their savings effortlessly. Goodbudget Based on the envelope budgeting system, Goodbudget helps users allocate funds into virtual envelopes for different spending categories. It encourages deliberate financial choices and prevents overspending. The Psychology Behind Mindful Spending Understanding the psychological aspects of spending can enhance the effectiveness of mindful practices. Here are some key concepts: Impulse Control: Apps with built-in spending alerts or reminders can help curb impulsive purchases by prompting users to reflect before they buy. Reward Systems: Many apps gamify savings by offering badges, streaks, or other incentives to motivate users. Anchoring Effect: By setting a budget or goal, you anchor your spending decisions to that reference point, reducing the temptation to overspend. Benefits of Using Mindful Spending and Saving Apps Improved Financial Awareness: Tracking your expenses and savings provides a clearer understanding of your financial habits. Reduced Stress: Knowing you’re in control of your finances alleviates the anxiety often associated with money management. Goal Achievement: These apps make it easier to set and achieve financial goals, whether they’re short-term or long-term. Better Decision-Making: With real-time insights and reminders, you’re more likely to make intentional choices that align with your values. Time Savings: Automation features save time and effort, allowing you to focus on other aspects of your life. How to Choose the Right App for You With so many options available, selecting the right app can be overwhelming. Consider the following factors: Ease of Use: Choose an app with an intuitive interface that matches your level of tech-savviness. Features: Identify your primary needs, such as budgeting, saving, or investing, and select an app that excels in those areas. Cost: While some apps are free, others may charge subscription fees. Evaluate whether the benefits justify the expense. Compatibility: Ensure the app integrates with your existing financial accounts and devices. Privacy and Security: Opt for apps with robust data encryption and privacy policies to protect your information. Tips for Maximizing the Impact of Financial Apps Set Realistic Goals: Start with achievable targets to build momentum and confidence. Review Regularly: Schedule weekly or monthly check-ins to assess your progress and adjust your strategy. Engage with Features: Explore all the tools and resources offered by the app to maximize its benefits. Stay Consistent: Consistency is key to building sustainable habits. Combine with Other Strategies: Pair app usage with other mindful spending practices, such as journaling or financial literacy education. The Future of Mindful Spending and Saving Apps Financial apps are becoming smarter and more personalized. Features like AI-driven insights, predictive analytics, and integration with wearable devices are on the rise. These advancements aim to make financial management even more seamless and intuitive. Additionally, the focus on financial wellness is expanding to include mental and emotional aspects. Some apps now offer resources for stress management and behavioral coaching, acknowledging the deep connection between money and overall well-being. Conclusion Mindful spending and saving apps are more than just tools; they’re catalysts for transforming financial habits and empowering individuals to make intentional choices. By aligning technology with personal values, these apps pave the way for a healthier relationship with money. Whether you’re looking to get out of debt, save for a dream goal, or simply achieve better financial balance, there’s an app to support your journey. Start exploring today and take the first step toward a more mindful and secure financial future. Related Items: Better Decision-Making , Money Saving Apps , Time Savings Share Tweet Share Share Email Recommended for you Risk Assessment and Underwriting Platforms: AI for Better Decision-Making The Top 8 Benefits of Using Learning Management Systems Money Saving Magic! Discover The Best Money Saving Apps For 2023 Comments